
Live Brucellosis Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
Description
Live Brucellosis Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
Live Brucellosis Vaccine Market Overview
The global market for Live Brucellosis Vaccines is witnessing steady growth driven by increasing awareness about animal health and the growing demand for controlling brucellosis,a zoonotic disease that affects livestock and can be transmitted to humans. Brucellosis remains a significant concern in the agricultural sector,especially in countries with large livestock populations. As a result,vaccination programs for cattle,sheep,and pigs are critical in controlling the spread of this disease. Various vaccine strains,including RB-51,S19,S2,A19,and Rev. I,are in demand due to their effectiveness in preventing brucellosis in different animal species.
Market Size
The Live Brucellosis Vaccine market is expected to grow at a compound annual growth rate (CAGR) of 4.5% to 6.5% over the forecast period of 2025-2030. This growth is primarily driven by ongoing vaccination campaigns,particularly in developing regions,as well as increasing government support for livestock health initiatives.
Market Share & Trends Analysis
By Product Type
The Live Brucellosis Vaccine market is segmented by vaccine strain,with several key strains dominating the market:
- Strain RB-51: This strain is the most widely used in the market due to its effectiveness and lower likelihood of causing adverse reactions in vaccinated animals. The RB-51 strain is expected to hold a market share of 30% to 35%,with a CAGR of 5.0% to 6.0%.
- Strain S19: Historically one of the most used strains,S19 is still in demand due to its established track record in cattle. It holds a market share of 25% to 30% and is projected to grow at a CAGR of 4.5% to 5.5% over the forecast period.
- Strain S2: This strain is used primarily for sheep and is expected to maintain a market share of 10% to 15%,with a growth rate of 4.0% to 5.0%.
- Strain A19: Primarily used for pigs,this strain is forecast to have a market share of 10% to 15%,growing at a CAGR of 4.5% to 5.5%.
- Strain Rev. I: A newer vaccine strain used in specific regions,Rev. I is expected to capture 5% to 10% of the market,with a CAGR of 5.5% to 6.5%.
By Application
The applications for Live Brucellosis Vaccines include cattle,sheep,pigs,and other livestock species:
- Cattle: The largest segment,cattle vaccination remains a critical part of brucellosis control programs. This segment is expected to account for 50% to 55% of the market share,with a CAGR of 5.0% to 6.0%.
- Sheep: The sheep vaccination segment is growing as brucellosis continues to impact sheep farming in certain regions. It is projected to hold 20% to 25% of the market share,growing at a CAGR of 4.5% to 5.5%.
- Pig: Brucellosis vaccination in pigs is crucial for disease prevention in swine farms,contributing around 15% to 20% of the market. This segment is expected to grow at a CAGR of 4.0% to 5.0%.
- Others: Other applications,including in goats and other livestock species,make up a smaller segment of the market,accounting for 5% to 10% of the market share,with a CAGR of 3.5% to 4.5%.
By Key Players
The Live Brucellosis Vaccine market is competitive,with several leading players driving innovation and supply:
- CZ Vaccines: A prominent manufacturer of veterinary vaccines,including those for brucellosis,contributing significantly to the global market.
- MSD Animal Health: A major player in the animal health industry,MSD offers a range of brucellosis vaccines for livestock.
- Ceva: Known for its veterinary vaccine solutions,Ceva is a key player in the development of brucellosis vaccines.
- Colorado Serum: A leading supplier of animal health products,including vaccines for brucellosis prevention.
- Tecnovax: Specializes in providing high-quality vaccines for livestock,with a focus on brucellosis control.
- Syva: A key manufacturer of veterinary vaccines,including for brucellosis,catering to the global market.
- Shchelkovo Biocombinat: A major producer of veterinary vaccines,including live brucellosis vaccines,in Russia and surrounding regions.
- Jinyu Baoling: A Chinese producer of vaccines,contributing to the Asian market for animal health products.
- Biovet: Known for its strong presence in the Latin American and European markets,Biovet offers brucellosis vaccines to various regions.
- CAVAC: A leader in the development and production of animal vaccines,including brucellosis vaccines.
- VETAL: Specializes in animal health products,including vaccines for brucellosis prevention.
- Indian Immunologicals: A major player in India,producing vaccines for a range of animal diseases,including brucellosis.
- Dollvet: Known for producing veterinary vaccines,including for brucellosis,in emerging markets.
- Hester Biosciences: Focused on producing vaccines for various animal diseases,including brucellosis,with a strong market presence in India.
- Qilu Animal Health: A Chinese company producing veterinary vaccines,including those for brucellosis,for domestic and international markets.
- Auleon Biologicals: Known for producing brucellosis vaccines and other biologics for animal health.
By Region
The Live Brucellosis Vaccine market is influenced by regional vaccination programs and disease control efforts:
- North America: Dominates the market,accounting for 30% to 35% of the market share. This region is expected to grow at a CAGR of 4.5% to 5.5%,driven by ongoing disease prevention and livestock health initiatives.
- Europe: A key market for brucellosis vaccines,with significant demand in both Eastern and Western Europe. Europe is expected to hold 20% to 25% of the market share,growing at a CAGR of 4.0% to 5.0%.
- Asia-Pacific: Rapidly growing market,particularly in China and India,where large livestock populations drive demand. The region is forecast to grow at a CAGR of 5.0% to 6.0%,with a market share of 25% to 30%.
- Latin America: A major market for brucellosis vaccination programs,particularly in Brazil and Argentina. Latin America holds 15% to 20% of the market share,with a projected growth rate of 4.5% to 5.5%.
- Middle East & Africa: An emerging market for brucellosis vaccines,expected to hold 5% to 10% of the market share,growing at a CAGR of 4.0% to 5.0%.
Segment Forecasts (2025-2030)
Growth in Key Segments
- Strain RB-51: Expected to continue its dominance with a CAGR of 5.0% to 6.0%.
- Cattle Application: Projected to remain the largest segment,growing at a CAGR of 5.0% to 6.0%.
- Asia-Pacific Region: Expected to experience the highest growth rate in the market,with a CAGR of 5.0% to 6.0%.
Table of Contents
- Chapter 1 Executive Summary
- Chapter 2 Abbreviation and Acronyms
- Chapter 3 Preface
- 3.1 Research Scope
- 3.2 Research Sources
- 3.2.1 Data Sources
- 3.2.2 Assumptions
- 3.3 Research Method
- Chapter Four Market Landscape
- 4.1 Market Overview
- 4.2 Classification/Types
- 4.3 Application/End Users
- Chapter 5 Market Trend Analysis
- 5.1 Introduction
- 5.2 Drivers
- 5.3 Restraints
- 5.4 Opportunities
- 5.5 Threats
- Chapter 6 Industry Chain Analysis
- 6.1 Upstream/Suppliers Analysis
- 6.2 Live Brucellosis Vaccine Analysis
- 6.2.1 Technology Analysis
- 6.2.2 Cost Analysis
- 6.2.3 Market Channel Analysis
- 6.3 Downstream Buyers/End Users
- Chapter 7 Latest Market Dynamics
- 7.1 Latest News
- 7.2 Merger and Acquisition
- 7.3 Planned/Future Project
- 7.4 Policy Dynamics
- Chapter 8 Historical and Forecast Live Brucellosis Vaccine Market in North America (2020-2030)
- 8.1 Live Brucellosis Vaccine Market Size
- 8.2 Live Brucellosis Vaccine Market by End Use
- 8.3 Competition by Players/Suppliers
- 8.4 Live Brucellosis Vaccine Market Size by Type
- 8.5 Key Countries Analysis
- 8.5.1 United States
- 8.5.2 Canada
- 8.5.3 Mexico
- Chapter 9 Historical and Forecast Live Brucellosis Vaccine Market in South America (2020-2030)
- 9.1 Live Brucellosis Vaccine Market Size
- 9.2 Live Brucellosis Vaccine Market by End Use
- 9.3 Competition by Players/Suppliers
- 9.4 Live Brucellosis Vaccine Market Size by Type
- 9.5 Key Countries Analysis
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Chile
- 9.5.4 Peru
- Chapter 10 Historical and Forecast Live Brucellosis Vaccine Market in Asia & Pacific (2020-2030)
- 10.1 Live Brucellosis Vaccine Market Size
- 10.2 Live Brucellosis Vaccine Market by End Use
- 10.3 Competition by Players/Suppliers
- 10.4 Live Brucellosis Vaccine Market Size by Type
- 10.5 Key Countries Analysis
- 10.5.1 China
- 10.5.2 India
- 10.5.3 Japan
- 10.5.4 South Korea
- 10.5.5 Southest Asia
- 10.5.6 Australia
- Chapter 11 Historical and Forecast Live Brucellosis Vaccine Market in Europe (2020-2030)
- 11.1 Live Brucellosis Vaccine Market Size
- 11.2 Live Brucellosis Vaccine Market by End Use
- 11.3 Competition by Players/Suppliers
- 11.4 Live Brucellosis Vaccine Market Size by Type
- 11.5 Key Countries Analysis
- 11.5.1 Germany
- 11.5.2 France
- 11.5.3 United Kingdom
- 11.5.4 Italy
- 11.5.5 Spain
- 11.5.6 Belgium
- 11.5.7 Netherlands
- 11.5.8 Austria
- 11.5.9 Poland
- 11.5.10 Russia
- Chapter 12 Historical and Forecast Live Brucellosis Vaccine Market in MEA (2020-2030)
- 12.1 Live Brucellosis Vaccine Market Size
- 12.2 Live Brucellosis Vaccine Market by End Use
- 12.3 Competition by Players/Suppliers
- 12.4 Live Brucellosis Vaccine Market Size by Type
- 12.5 Key Countries Analysis
- 12.5.1 Egypt
- 12.5.2 Israel
- 12.5.3 South Africa
- 12.5.4 Gulf Cooperation Council Countries
- 12.5.5 Turkey
- Chapter 13 Summary For Global Live Brucellosis Vaccine Market (2020-2025)
- 13.1 Live Brucellosis Vaccine Market Size
- 13.2 Live Brucellosis Vaccine Market by End Use
- 13.3 Competition by Players/Suppliers
- 13.4 Live Brucellosis Vaccine Market Size by Type
- Chapter 14 Global Live Brucellosis Vaccine Market Forecast (2025-2030)
- 14.1 Live Brucellosis Vaccine Market Size Forecast
- 14.2 Live Brucellosis Vaccine Application Forecast
- 14.3 Competition by Players/Suppliers
- 14.4 Live Brucellosis Vaccine Type Forecast
- Chapter 15 Analysis of Global Key Vendors
- 15.1 CZ Vaccines
- 15.1.1 Company Profile
- 15.1.2 Main Business and Live Brucellosis Vaccine Information
- 15.1.3 SWOT Analysis of CZ Vaccines
- 15.1.4 CZ Vaccines Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.2 MSD
- 15.2.1 Company Profile
- 15.2.2 Main Business and Live Brucellosis Vaccine Information
- 15.2.3 SWOT Analysis of MSD
- 15.2.4 MSD Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.3 Ceva
- 15.3.1 Company Profile
- 15.3.2 Main Business and Live Brucellosis Vaccine Information
- 15.3.3 SWOT Analysis of Ceva
- 15.3.4 Ceva Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.4 Colorado Serum
- 15.4.1 Company Profile
- 15.4.2 Main Business and Live Brucellosis Vaccine Information
- 15.4.3 SWOT Analysis of Colorado Serum
- 15.4.4 Colorado Serum Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.5 Tecnovax
- 15.5.1 Company Profile
- 15.5.2 Main Business and Live Brucellosis Vaccine Information
- 15.5.3 SWOT Analysis of Tecnovax
- 15.5.4 Tecnovax Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.6 Syva
- 15.6.1 Company Profile
- 15.6.2 Main Business and Live Brucellosis Vaccine Information
- 15.6.3 SWOT Analysis of Syva
- 15.6.4 Syva Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.7 Shchelkovo Biocombinat
- 15.7.1 Company Profile
- 15.7.2 Main Business and Live Brucellosis Vaccine Information
- 15.7.3 SWOT Analysis of Shchelkovo Biocombinat
- 15.7.4 Shchelkovo Biocombinat Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.8 Jinyu Baoling
- 15.8.1 Company Profile
- 15.8.2 Main Business and Live Brucellosis Vaccine Information
- 15.8.3 SWOT Analysis of Jinyu Baoling
- 15.8.4 Jinyu Baoling Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.9 Biovet
- 15.9.1 Company Profile
- 15.9.2 Main Business and Live Brucellosis Vaccine Information
- 15.9.3 SWOT Analysis of Biovet
- 15.9.4 Biovet Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- 15.10 CAVAC
- 15.10.1 Company Profile
- 15.10.2 Main Business and Live Brucellosis Vaccine Information
- 15.10.3 SWOT Analysis of CAVAC
- 15.10.4 CAVAC Live Brucellosis Vaccine Revenue, Gross Margin and Market Share (2020-2025)
- Please ask for sample pages for full companies list
- Tables and Figures
- Table Abbreviation and Acronyms
- Table Research Scope of Live Brucellosis Vaccine Report
- Table Data Sources of Live Brucellosis Vaccine Report
- Table Major Assumptions of Live Brucellosis Vaccine Report
- Figure Market Size Estimated Method
- Figure Major Forecasting Factors
- Figure Live Brucellosis Vaccine Picture
- Table Live Brucellosis Vaccine Classification
- Table Live Brucellosis Vaccine Applications
- Table Drivers of Live Brucellosis Vaccine Market
- Table Restraints of Live Brucellosis Vaccine Market
- Table Opportunities of Live Brucellosis Vaccine Market
- Table Threats of Live Brucellosis Vaccine Market
- Table Covid-19 Impact For Live Brucellosis Vaccine Market
- Table Raw Materials Suppliers
- Table Different Production Methods of Live Brucellosis Vaccine
- Table Cost Structure Analysis of Live Brucellosis Vaccine
- Table Key End Users
- Table Latest News of Live Brucellosis Vaccine Market
- Table Merger and Acquisition
- Table Planned/Future Project of Live Brucellosis Vaccine Market
- Table Policy of Live Brucellosis Vaccine Market
- Table 2020-2030 North America Live Brucellosis Vaccine Market Size
- Figure 2020-2030 North America Live Brucellosis Vaccine Market Size and CAGR
- Table 2020-2030 North America Live Brucellosis Vaccine Market Size by Application
- Table 2020-2025 North America Live Brucellosis Vaccine Key Players Revenue
- Table 2020-2025 North America Live Brucellosis Vaccine Key Players Market Share
- Table 2020-2030 North America Live Brucellosis Vaccine Market Size by Type
- Table 2020-2030 United States Live Brucellosis Vaccine Market Size
- Table 2020-2030 Canada Live Brucellosis Vaccine Market Size
- Table 2020-2030 Mexico Live Brucellosis Vaccine Market Size
- Table 2020-2030 South America Live Brucellosis Vaccine Market Size
- Figure 2020-2030 South America Live Brucellosis Vaccine Market Size and CAGR
- Table 2020-2030 South America Live Brucellosis Vaccine Market Size by Application
- Table 2020-2025 South America Live Brucellosis Vaccine Key Players Revenue
- Table 2020-2025 South America Live Brucellosis Vaccine Key Players Market Share
- Table 2020-2030 South America Live Brucellosis Vaccine Market Size by Type
- Table 2020-2030 Brazil Live Brucellosis Vaccine Market Size
- Table 2020-2030 Argentina Live Brucellosis Vaccine Market Size
- Table 2020-2030 Chile Live Brucellosis Vaccine Market Size
- Table 2020-2030 Peru Live Brucellosis Vaccine Market Size
- Table 2020-2030 Asia & Pacific Live Brucellosis Vaccine Market Size
- Figure 2020-2030 Asia & Pacific Live Brucellosis Vaccine Market Size and CAGR
- Table 2020-2030 Asia & Pacific Live Brucellosis Vaccine Market Size by Application
- Table 2020-2025 Asia & Pacific Live Brucellosis Vaccine Key Players Revenue
- Table 2020-2025 Asia & Pacific Live Brucellosis Vaccine Key Players Market Share
- Table 2020-2030 Asia & Pacific Live Brucellosis Vaccine Market Size by Type
- Table 2020-2030 China Live Brucellosis Vaccine Market Size
- Table 2020-2030 India Live Brucellosis Vaccine Market Size
- Table 2020-2030 Japan Live Brucellosis Vaccine Market Size
- Table 2020-2030 South Korea Live Brucellosis Vaccine Market Size
- Table 2020-2030 Southeast Asia Live Brucellosis Vaccine Market Size
- Table 2020-2030 Australia Live Brucellosis Vaccine Market Size
- Table 2020-2030 Europe Live Brucellosis Vaccine Market Size
- Figure 2020-2030 Europe Live Brucellosis Vaccine Market Size and CAGR
- Table 2020-2030 Europe Live Brucellosis Vaccine Market Size by Application
- Table 2020-2025 Europe Live Brucellosis Vaccine Key Players Revenue
- Table 2020-2025 Europe Live Brucellosis Vaccine Key Players Market Share
- Table 2020-2030 Europe Live Brucellosis Vaccine Market Size by Type
- Table 2020-2030 Germany Live Brucellosis Vaccine Market Size
- Table 2020-2030 France Live Brucellosis Vaccine Market Size
- Table 2020-2030 United Kingdom Live Brucellosis Vaccine Market Size
- Table 2020-2030 Italy Live Brucellosis Vaccine Market Size
- Table 2020-2030 Spain Live Brucellosis Vaccine Market Size
- Table 2020-2030 Belgium Live Brucellosis Vaccine Market Size
- Table 2020-2030 Netherlands Live Brucellosis Vaccine Market Size
- Table 2020-2030 Austria Live Brucellosis Vaccine Market Size
- Table 2020-2030 Poland Live Brucellosis Vaccine Market Size
- Table 2020-2030 Russia Live Brucellosis Vaccine Market Size
- Table 2020-2030 MEA Live Brucellosis Vaccine Market Size
- Figure 2020-2030 MEA Live Brucellosis Vaccine Market Size and CAGR
- Table 2020-2030 MEA Live Brucellosis Vaccine Market Size by Application
- Table 2020-2025 MEA Live Brucellosis Vaccine Key Players Revenue
- Table 2020-2025 MEA Live Brucellosis Vaccine Key Players Market Share
- Table 2020-2030 MEA Live Brucellosis Vaccine Market Size by Type
- Table 2020-2030 Egypt Live Brucellosis Vaccine Market Size
- Table 2020-2030 Israel Live Brucellosis Vaccine Market Size
- Table 2020-2030 South Africa Live Brucellosis Vaccine Market Size
- Table 2020-2030 Gulf Cooperation Council Countries Live Brucellosis Vaccine Market Size
- Table 2020-2030 Turkey Live Brucellosis Vaccine Market Size
- Table 2020-2025 Global Live Brucellosis Vaccine Market Size by Region
- Table 2020-2025 Global Live Brucellosis Vaccine Market Size Share by Region
- Table 2020-2025 Global Live Brucellosis Vaccine Market Size by Application
- Table 2020-2025 Global Live Brucellosis Vaccine Market Share by Application
- Table 2020-2025 Global Live Brucellosis Vaccine Key Vendors Revenue
- Figure 2020-2025 Global Live Brucellosis Vaccine Market Size and Growth Rate
- Table 2020-2025 Global Live Brucellosis Vaccine Key Vendors Market Share
- Table 2020-2025 Global Live Brucellosis Vaccine Market Size by Type
- Table 2020-2025 Global Live Brucellosis Vaccine Market Share by Type
- Table 2025-2030 Global Live Brucellosis Vaccine Market Size by Region
- Table 2025-2030 Global Live Brucellosis Vaccine Market Size Share by Region
- Table 2025-2030 Global Live Brucellosis Vaccine Market Size by Application
- Table 2025-2030 Global Live Brucellosis Vaccine Market Share by Application
- Table 2025-2030 Global Live Brucellosis Vaccine Key Vendors Revenue
- Figure 2025-2030 Global Live Brucellosis Vaccine Market Size and Growth Rate
- Table 2025-2030 Global Live Brucellosis Vaccine Key Vendors Market Share
- Table 2025-2030 Global Live Brucellosis Vaccine Market Size by Type
- Table 2025-2030 Live Brucellosis Vaccine Global Market Share by Type
Pricing
Currency Rates